biomedicina slovenica

pr=Cleland : 18

  1. Coats Andrew J.; Heymans Stephane; Farmakis Dimitrios; Anker Stefan D.; Bauersachs Johann; Boer Rudolph A. de; Čelutkienè Jelena; Cleland John G.; Jankowska Eva A.; Lainščak Mitja
    Atrial disease and heart failure
    2022 ►
  2. Von Haehling Stephan; Valentova Miroslava; Anker Marcus S.; Ebner Nicole; Bekfani Tarek; Haarmann Helge; Schefold Joerg C.; Lainščak Mitja; Cleland John G.; Doehner Wolfram
    Muscle wasting as an independent predictor of survival in patients with chronic heart failure
    2020 ►
  3. Seferović Petar M.; Ponikowski Piotr; Anker Stefan D.; Bauersachs Johann; Chioncel Ovidiu; Cleland John G.; Boer Rudolph A. de; Drexel Heinz; Gal Tuvia Ben; Lainščak Mitja
    Clinical practice update on heart failure 2019
    2019 ►
  4. Mueller Christian; Boer Rudolph A. de; Maisel Alan; Cleland John G.; Kozhuharov Nikola; Coats Andrew J.; Metra Marco; Mebazaa Alexandre; Ruschitzka Frank; Lainščak Mitja
    Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
    2019 ►
  5. Bekfani Tarek; Pellicori Pierpaolo; Morris Daniel A.; Ebner Nicole; Valentova Miroslava; Sandek Anja; Doehner Wolfram; Cleland John G.; Lainščak Mitja; Anker Stefan D.
    Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life
    2019 ►
  6. Abraham William T.; Cleland John G.; Coats Andrew J.; Jankowska Eva A.; Lainščak Mitja; Lopatin Yuri; Metra Marco; Rosano Giuseppe M.; Seferović Petar M.
    Clinical heart failure management
    2016 ►
  7. Lainščak Mitja; Coletta Alison P; Sherwi Nasser; Cleland John G
    Clinical trials update from the Heart failure society of America meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1
    2009 ►
  8. Farkaš Jerneja; Nabb Samantha; Zaletel-Kragelj Lijana; Cleland John GF; Lainščak Mitja
    Self-rated health and mortality in patients with chronic heart failure
    2009 ►
  9. Lainščak Mitja; Anker Stefan D; Cleland John G
    Smoking cessation in heart failure: easier said than done
    2009 ►
  10. Farkaš J; Nabb SL; Zaletel-Kragelj L; Cleland JGF; Lainščak M
    Self-rated health in patients with chronic heart failure: distribution and association with mortality
    2008 ►
  11. Lainščak Mitja; Cleland JG; Lenzen MJ; Nabb S; Keber I; Follath F; Komajda M; Swedberg K
    Recall of lifestyle advice in patients recently hospitalised with heart failure: A EuroHeart Failure Survey analysis
    2007 ►
  12. Lainščak Mitja; Cleland John GF; Lenzen Mattie J; Keber Irena; Goode Kevin; Follath Ferenc; Komajda Michel; Swedberg Karl
    Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart failure survey
    2007 ►
  13. Lainščak M; Keber I; Lenzen MJ; Follath F; Swedberg K; Komajda M; Cleland JGF
    Lifestyle advice in hospitalized heart failure patients: experience from the EuroHeart failure survey
    2006 ►
  14. Lainščak Mitja; Cleland John GF; Lenzen Mattie J; Follath Ferenc; Komajda Michel; Swedberg Karl
    International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart failure survey
    2007 ►
  15. Lainščak Mitja; Keber I; Lenzen MJ; Follath F; Swedberg K; Komajda M; Cleland JGF
    Inadequate recall of advice on diet and lifestyle in patients with heart failure: experience from the Euro heart failure survey
    2005 ►
  16. Lainščak Mitja; Komajda M; Keber I; Lenzen MJ; Follath F; Swedberg K; Cleland JGF
    Advice on non-pharmacological measures to patients after hospitalisation for heart failure is insufficient: experience from the European failure survey
    2005 ►
  17. Lainščak M; Cleland JGF; Lenzen M; Follath F; Komajda M; Swedberg K
    International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the Euro heart failure survey
    2005 ►
  18. Massie Barry M; Armstrong Paul W; Cleland John GF; Horowitz John D; Pecker Milton; Poole-Wilson Philip A; Ryden Lars
    Toleranca velikih odmerkov zaviralcev angiotenzin-konvertirajočega encima pri bolnikih s kroničnim srčnim popuščanjem: rezultati študije ATLAS
    [(Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure. Result from the ATLAS trial)]
    2001 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics